Bladder Cancer Paradigm Expanding to Include Immunotherapy Combos, Targeted Therapies – OncLive
OncLiveBladder Cancer Paradigm Expanding to Include Immunotherapy Combos, Targeted TherapiesOncLiveThe bladder cancer community has generated excitement with 5 monotherapy approvals for PD-1/PD-L1 inhibitors within the last year, including nivolumab (… Continue reading
